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Most mammalian cells must adhere to the extracellular matrix (ECM) to maintain proper growth and development.
Fibronectin is a predominant ECM protein that engages integrin cell receptors through its Arg-Gly-Asp (RGD) and
Pro-His-Ser-Arg-Asn (PHSRN) peptide binding sites. To study the roles these motifs play in cell adhesion, proteins
derived from the 9th (containing PHSRN) and 10th (containing RGD) type III fibronectin domains were engineered to
be in frame with cutinase, a serine esterase that forms a site-specific, covalent adduct with phosphonate ligands. Self-
assembled monolayers (SAMs) that present phosphonate ligands against an inert background of tri(ethylene glycol)
groups were used as model substrates to immobilize the cutinase-fibronectin fusion proteins. Baby hamster kidney cells
attached efficiently to all protein surfaces, but only spread efficiently on protein monolayers containing the RGD
peptide. Cells on RGD-containing protein surfaces also displayed defined focal adhesions and organized cytoskeletal
structures compared to cells on PHSRN-presenting surfaces. Cell attachment and spreading were shown to be
unaffected by the presence of PHSRN when compared to RGD alone on SAMs presenting higher densities of protein,
but PHSRN supported an increased efficiency in cell attachment when presented at low protein densities with RGD.
Treatment ofsuspended cells withsoluble RGDorPHSRN peptidesrevealedthatbothpeptideswereable toinhibit the
attachment of FN10 surfaces. These results support a model wherein PHSRN and RGD bind competitively to
integrins;ratherthanatwo-pointsynergisticinteraction;andthepresenceofPHSRNservestoincreasethedensityof
ligand on the substrate and therefore enhance the sticking probability of cells during attachment.
Introduction
The extracellular matrix (ECM) is an insoluble aggregate of
fibrous proteins and glycosaminoglycans that serves as the scaf-
fold that organizes the adhesion, growth, and differentiation of
mammalian cells.
1-3 In most cases, the integrin receptors;a
family of heterodimeric proteins that span the cell membrane;
mediate the adhesion of cells to the ECM and transduce both
internal and external signals that regulate cellular processes.
4-6
The large number of ligands present in the ECM make it difficult
toidentifythecombinationsofligandsandreceptorsthatinteract
and to understand the downstream activities that result from
these interactions.
7,8 Model substrates that present defined bind-
ing motifs from ECM proteins have served an important role in
addressing this challenge, yet the complications inherent to the
immobilization of proteins on culture substrates;including the
tendency for proteins to denature and adsorb in nonproductive
orientations;can complicate the interpretation of experiments
that use model substrates. In this paper, we use self-assembled
monolayers (SAMs) that present cell binding domains from
fibronectin (FN) as model substrates to address the roles of the
FN RGD and PHSRN ligands in cell adhesion.
FN is an ECM protein having a linear arrangement of about
thirty domains that includes peptide ligands that mediate the
adhesion, spreading, and migration of cells.
9-12 The small peptide
Arg-Gly-Asp (RGD) is the prototypical ligand and is located in the
10th type III domain of FN (FN10), where it interacts with several
integrin receptors to mediate cell adhesion.
13-15 While this peptide
remains the best understood ligand in FN, a substantial effort has
addressedthediscoveryandfunctionofadditionalligandsthatplay
roles in cell adhesion. Early studies used site-directed mutagenesis
and antibody blocking experiments to reveal a motif within the 9th
type III domain that also influenced R5β1 integrin-mediated cell
adhesion with baby hamster kidney (BHK) fibroblasts.
16-19
Further mutational studies of this region subsequently identified
the specific sequence as Pro-His-Ser-Arg-Asn (PHSRN).
20,21
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Adhesion studies of HT-1080 and BHK-21 cells to surfaces that
were modified by the adsorption of recombinant fragments of FN
led to the suggestion that the PHSRN peptide was a synergy ligand
in R5β1 integrin-mediated adhesion, since cells were observed to
attach and spread to a greater degree on surfaces that presented
both the 9th and 10th domains relative to those that presented the
10th domain alone, but cells did not attach to surfaces that lacked
the RGD sequence.
17,21-23 Several experiments suggested that
the relative spacing of the PHSRN and RGD peptides within FN
were important to this synergistic activity, including poor adhesion
to proteins having altered linkers between the 9th and 10th
domains,
17,24 molecular models,
20,21 and X-ray crystallographic
structures of the FN7-10 domains
25 as well as the extracellular
region of integrin RVβ3.
26 These studies led to the suggestion that
the RGD and PHSRN peptides could interact with different faces
of a single R5β1 integrin, leading to an increased affinity of the
receptor when both peptide ligands were present. In this model, the
PHSRN peptide presumably has an affinity that is insufficient to
mediate adhesion on its own, a feature that is supported by BHK
cell adhesion experiments.
22,24 Several studies reported results that
are consistent with the synergistic binding model.
27-31
Other work, however, has found that the RGD and PHSRN
ligands bind competitively to the integrin receptor, either by
interacting with overlapping regions of the integrin receptor or
with nonoverlapping sites that are allosterically connected. In a
previous study, we used SAMs that presented the two peptides
against an otherwise inert background to find that BHK-21 and
NIH-3T3 fibroblast cells use the R5β1i n t e g r i nt oa t t a c ht o
surfaces presenting the PHSRN peptide alone, and that this
attachment could be blocked by either soluble RGD or
PHSRN.
32 That study also showed that PHSRN has a lower
affinity for the integrin receptor than does the RGD peptide,
consistentwiththepoorspreadingofadherentcellsontheformer.
Other reports have supported the finding that PHSRN alone is
able to mediate 3T3 fibroblast and PC12 pheocytochroma cell
attachment.
33,34 In addition, a previous study investigated β1-
mediated adhesion and observed PAC1 cell attachment and
spreading on several surfaces coated with various recombinant
FN type III domains lacking the RGD sequence as long as the
integrinshadbeenexternallyactivated,
35therebyshowingthatβ1
integrin-mediated cell attachment may not require the RGD
motif. The competitive binding of the PHSRN and RGD ligands
to the integrin receptor has also been demonstrated for RIIbβ3
integrins, where both PHSRN and RGD peptides were shown to
inhibit the binding of the integrin with FN.
20 That study also
found that the PHSRN peptide had a lower binding affinity for
the integrin than did the RGD peptide, in agreement with our
report that used monolayers as model substrates. Collectively,
this body of work establishes that the PHSRN motif plays a role
in mediating cell adhesion and suggests a revision of the mechan-
ism by which PHSRN and RGD cooperate in adhesion.
Theconflictingresultssummarizedabovesteminpartfromthe
different approaches usedto mimicthe ECM.The most common
approaches rely on the adsorption of recombinant or purified
proteins to glass or plastic cultureware and have the primary
limitation that the activities of the adsorbed proteins are difficult
to determine or to control. Because proteins adsorb with a range
of orientations and undergo denaturation to various degrees, the
fraction of protein that presents ligand in a state that can interact
with cell-surface receptors is often unknown. Studies frequently
make the assumption that surfaces presenting proteins that are
substantially the same will adsorb in a similar manner to give a
constant activity. Yet, several studies have shown that even a
single site mutation can dramatically affect the adsorption of
proteins. Two cytochrome 5 proteins that only differed in the
swapping of two residues were found to adsorb with kinetics that
differed by 20-fold.
36 It is also the case that the choice of material
can have a dramatic effect on the activity of an adsorbed protein.
One study compared three different polystyrene surfaces that
were coated with FN and found that C2C12 myoblast cells
displayed differences in growth and differentiation simply be-
cause, upon adsorption, the FN was not presented in the same
manner for each substrate.
37 Another study found that positively
charged, negatively charged, or neutral surfaces that were subse-
quentlycoatedwithFNresultedincellswithdistinctdifferencesin
focal adhesion distributions, signaling activities, and osteoblast
differentiation rates.
38
These challenges with protein-coated substrates have led many
groups to employ peptide-modified substrates, where orientation
and structure of the active ligands can be controlled better.
39-42
Evenherethough,nonspecificadsorptionofproteintothesurface
can alter the ligands that are presented to a cell, and the
microenvironment around peptides can strongly affect cell adhe-
sion.
43-45 It is the affinities of the immobilized peptides that are
differentially impacted by adsorption, and there is the risk that
adsorption leads to a loss of affinity of the immobilized peptide.
There is also the view that protein-modified substrates have a
higherrelevancetotheECMthandopeptide-modifiedsubstrates
and are therefore preferred.
46-48
ThepresentworkusesSAMsubstratestopresent recombinant
protein domains from FN to study the roles of the PHSRN and
RGD motifs in mediating cell adhesion. These substrates are
effective models of the ECM because they present protein
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domains in a homogeneous microenvironment and with control
over density and orientation. Additionally, monolayers that
present the tri(ethylene glycol) group resist the nonspecific
adsorption of protein and maintain defined interactions between
the cell and the substrate. We show that BHK fibroblast cells
adhere to substrates that present PHSRN but lack RGD, con-
sistent with an earlier study in which peptide substrates were
used.
32 Interestingly, we initially did not observe a higher level
of cell attachment to surfaces presenting both ligands. For
substrates presenting lower densities of protein, however, we
find that the presence of PHSRN with RGD leads to more
efficient cell adhesion compared to substrates presenting RGD
alone. We also show that both soluble PHSRN and RGD
peptides are able to inhibit cell adhesion to substrates presenting
FN10, indicating that the two peptide ligands bind competitively
to the same site of the integrin receptor. The use of well-defined
protein substrates in this work supports a model where PHSRN
and RGD act as individual, competitive ligands to mediate
cell adhesion.
Experimental Methods
Protein Construction and Expression. The construction of
the vector containing the cutinase gene, pCut22b, was described
elsewhere.
49 The plasmid FNIII7-10(pET11b), containing the
7th, 8th, 9th, and 10th type III repeat domains of FN, was
provided by Dr. Harold Erickson (Duke University, Durham,
NC).
25 Details on the gene splicing by overlap extension poly-
merase chain reaction (SOEing PCR) technique and the primers
used to make the Cut-FN domain fusions can be found in the
Supporting Information. Separate constructs were prepared
for expression of Cut-FN9-10, Cut-FN9, Cut-FN10, Cut-
FN9-10m (where the RGD site was scrambled to RDG), Cut-
FN9m-10 (where the PHSRN site was scrambled to HRPSN),
and Cut-FN9m-10m (the double mutant form) shown in
Figure 1. All products were verified through DNA sequencing.
Cultures of BL21(DE3) cells (Invitrogen, Carlsbad, CA) con-
tainingtheplasmidsforeachCut-FNproteinweregrownat37C
to an OD600 of 0.5. Expression was then induced with 0.5 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG; Sigma, St. Louis,
MO). All the proteins except Cut-FN9 were expressed for 16-18
ha t2 2C. Cut-FN9 was expressed at 15 Cf o r1 6 -18 h to
increasetheyieldofthesolubleprotein.Thecellpelletswerelysed
via sonication into phosphate-buffered saline (PBS) containing
1  complete protease inhibitors (Roche, Indianapolis, IN). The
lysateswereclarifiedthroughcentrifugationandstoredat4Cfor
up to one month. Protein expression levels were determined by a
cutinase activity assay as described previously.
49
Preparation of SAM Substrates. Monolayer substrates
were prepared as described previously.
49,50 Briefly, titanium
(40 A ˚ )t h e ng o l d( 2 2 0A ˚ ) were evaporated onto glass coverslips
using an electron beam evaporator (Thermionics) at a rate of
0.2-0.4 nm/s at a pressure of 1.0   10
-6 Torr. Monolayers were
formed by immersing these substrates into an ethanolic solu-
tion containing a mixture of a symmetric tri(ethylene glycol)-
terminated disulfide (EG3) and an asymmetric disulfide with
tri(ethylene glycol) and maleimide head groups for 12-16 h at
room temperature. The disulfide reagents were used at a concen-
tration of0.5mMwith themaleimide-terminatedreagent present
atrelativefractions of5%to0.001%. All substrateswere washed
with ethanol and dried with a stream of nitrogen.
The phosphonate ligand was synthesized by modifying a
previouslydescribed method
49and wasdissolved ina 1:1 mixture
of PBS and ethanol at 0.01 mg/mL and applied to maleimide-
terminated monolayers for 2 h at room temperature (Figure 2A).
For the preparation of monolayers having very low densities of
phosphonate,the reagent wasdiluted with 6-mercapto-1-hexanol
(Sigma) in various molar ratios to decrease the phosphonate
ligand immobilized on the surface. In all cases, the surfaces were
rinsed with water and ethanol and dried under a stream of
nitrogen prior to use. The phosphonate-presenting SAMs were
immersed in crude bacterial lysates containing the recombinantly
expressed cutinase-fibronectin domain fusion proteins for 2 h to
covalently immobilize the desired protein to the SAMs. The
monolayers were then rinsed with 0.5% sodium dodecyl sulfate
(SDS) to remove noncovalently immobilized proteins,
49,51 fol-
lowed by PBS before use in cell adhesion experiments. Figure 2B
displaysthe schematic for Cut-FNdomain immobilization,while
Figure2CshowstheSAMDIspectrathatverifiesimmobilization
of the ligands.
Positive control surfaces were prepared by immersing the bare
gold surfaces in a 1 mM ethanolic solution of dodecanethiol
overnight. The surfaces were then rinsed with ethanol and dried
under nitrogen. Full-length human FN (Sigma), at 25 μg/mL in
PBS, was applied to the monolayersfor 2 h atroomtemperature.
These substrates were rinsed with PBS. Negative control surfaces
consisted of either EG3 monolayers that had formed overnight
and incubated with bacterial lysates containing the Cut-FN
domain proteins or phosphonate SAMs to which recombinantly
expressed cutinase was immobilized. In both of these cases, the
chips were rinsed with 0.5% SDS and PBS.
Matrix-Assisted Laser Desorption/Ionization Mass Spec-
trometry of SAMs (SAMDI). Following each step used to
prepare the substrates described above, the samples were char-
acterized by SAMDI mass spectrometry. Spectra were obtained
using a 4800 MALDI-TOF/TOF mass spectrometer (Applied
Biosystems, Framingham, MA) using 20,40,60-trihydroxyaceto-
phenone (10 mg/mL) in acetonitrile as the matrix for the lower
molecular weight substrates and R-cyano-4-hydroxycinnamic
acid (7.5 mg/mL) in acetone for the immobilized protein sub-
strates.
Cell Culture. BHK-21 cells (ATCC, Rockville, MD) were
cultured in low-glucose Dulbecco’s modified Eagle medium
(DMEM; GIBCO, Carlsbad, CA) supplemented with 2 mM
L-glutamine (GIBCO). NIH-3T3 cells (ATCC) were cultured in
high-glucose DMEM supplemented with 4 mM L-glutamine. In
both cases, the media were also supplemented with 10% fetal
bovine serum and 1  penicillin/streptomycin (GIBCO). Cells
were cultured at 37 C with 5% CO2.
Cell Adhesion Assays. Confluent monolayers of BHK or 3T3
cells were removed from culture flasks and counted. Thirty
thousand cells were added to monolayers measuring 1 cm
2 in size
and incubated on the monolayers for 1 h at 37 C with 5% CO2
before the chips were rinsed with fresh media. Live cell images
were captured using a charge-coupled device (CCD) camera
attached to an Axiovert 200 microscope from Zeiss and Openlab
software(Improvision,Lexington,MA).Thecellswerethenfixed
Figure 1. Constructs of the FN type III domains fused to the
C-terminal end of cutinase, where the mutated integrin-binding
peptide sites of the domains are indicated in gray.
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using 3.7% formaldehyde in PBS, and 40,6-diamidino-2-pheny-
lindole (DAPI; Molecular Probes, Eugene, OR) and Alexa
488-labeled phalloidin (Molecular Probes) were added at dilu-
tions of 1:10000 and 1:1000 to stain the nuclei and actin
filaments, respectively. After rinsing, the substrates were fluores-
cently imaged on the Axiovert 200. Images of the nuclei were
captured in five places for each chip through a 20  objective
(660 μmb y5 0 0μm field of view) and counted using a nucleus
counter plug-in for ImageJ (NIH). The total area of fluo-
rescence for each field was obtained by thresholding the actin
images and calculating the total fluorescent area using ImageJ.
The total area of fluorescence was then divided by the total
number of nuclei within the same fields to yield the average
cell area. Each type of cell adhesion experiment was repeated
in triplicate, and five images were captured per chip to ensure
the reproducibility of the results. Statistical analysis was done
following the Student’s t test.
Immunostaining. BHK cells were added to each substrate for
4 h with complete media to attach and spread. Substrates were
washed with PBS prior to fixation with 3.7% formaldehyde for
5 min, followed by 1 min of permeabilization with 0.3% Triton
X-100 in PBS and 1 h with blocking buffer (1% bovine serum
albumin (BSA), 5% goat serum, and 0.1% Triton X-100). Sub-
strates were then incubated with a mouse antihuman vinculin
(Sigma) primary antibody at 1:1000 in blocking buffer for 1 h,
followed by a goat antimouse IgG antibody labeled with Texas
Red (Molecular Probes) at a 1:1000 dilution, Alexa 488-labeled
phalloidin,andDAPI.Allsubstrateswererinsedthoroughlywith
blocking buffer and mounted with 80% glycerol. Fluorescent
images were captured using an Axiovert 200 with Openlab soft-
ware and a 100  objective.
Inhibition Assay. Suspensions of 50000 BHK cells in serum-
free media were incubated with soluble cyclic-RGDfC, GRGDS,
PHSRN, GRDGS, or HRPSN peptide inhibitors at concen-
trations ranging from 5 μM to 1 mM for 15 min at room tem-
perature. The linear peptides were synthesized using standard
Fmoc solid-phase synthesis (reagents from AnaSpec, San Jose,
CA), and the cyclic peptide was made as previously described.
52
Thecell-peptidesolutionswereaddedtoSAMspresentingeither
0.005% FN10 (for RGD inhibitions) or 0.001% FN10 (for
PHSRN inhibitions) and incubated for an additional 15 min at
37C.Thechipswerethentransferredtoacleanwellplate,rinsed
with PBS, and fixed with 3.7% formaldehyde in PBS. The nu-
clei of the fixed cells were stained with DAPI and counted in
eight different places for each substrate in three independent
experiments. The average level of cell attachment inhibition was
reported with respect to the control surfaces that included
no peptide inhibitors.
Results
Monolayer Substrates Presenting FN Domains. We de-
signed several cutinase-fibronectin fusion proteins to investigate
the roles of PHSRN and RGD in cell adhesion. We used the two
domains from FN that carry the RGD and PHSRN ligands to
prepare three native proteins (FN9-10, FN9, and FN10). We
also engineered three mutated proteins wherein the PHSRN
sequence was scrambled (HRPSN; FN9m-10), the RGD se-
quence was scrambled (RDG; FN9-10m), and where both
peptides were scrambled (FN9m-10m). These domains were
expressed as fusion proteins with cutinase and immobilized to
monolayers presenting phosphonate. The phosphonate group is
an irreversible ligand for cutinase and is used to covalently tether
proteins in a defined orientation to the monolayer.
49,51,53 This
feature, along with the EG3 groups that prevent the nonspecific
adsorption of protein,
54-56 allowed us to selectively immobilize
the constructs using crude bacterial lysates and without the need
for prior purification.
Extensive work has shown that SAMs are compatible with
matrix-assisted laser desorption/ionization mass spectrometry,
which allows for straightforward characterization of the ligands
Figure 2. (A) SAMs presenting a phosphonate capture ligand
for the covalent immobilization of cutinase-fibronectin fusion
proteins. (B) Substrates were prepared by first treating a malei-
mide-terminated monolayer with a phosphonate ligand and
then with a cutinase fusion protein to immobilize the FN
fragments. (C) SAMDI mass spectrometry was used to con-
firm the masses of the ligands presented on the surface after
each step.
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presented onthe surfaces.
57-61Wehavetermedthischaracteriza-
tion technique SAMDI and used this method to confirm the
immobilizationofeachCut-FNdomainproteintothemonolayer
substrates in this work (Figure 3). The resulting spectra display
peaks corresponding to the desired proteins as both the double-
and single-charged species, as has been seen previously with
SAMDI spectra of proteins.
59,60 Cut-FN9 and Cut-FN10 have
predicted molecular weights of 33 kDa, while Cut-FN9-10, Cut-
FN9-10m,Cut-FN9m-10,andCut-FN9m-10mhaveexpected
molecular weights of 43 kDa.
Cell Adhesion to the Monolayer Substrates. We first
verified that BHK cells would attach and spread on the FN9-
10 substrates with similar morphology as they do on the FN-
coated substrates typically used in adhesion studies. We seeded
the cells onto surfaces with adsorbed full length FN (Figure 4A)
andcomparedthelevelsofcellattachmentontoFN9-10surfaces
at 1% ligand density (Figure 4B). We observed that similar




number of cells that attached to FN9, FN10, FN9-10m, and
FN9m-10 (Figure 4 C-F) was similar to that for FN9-10.
However, cells on FN9 and FN9-10m surfaces were smaller and
exhibitedroundmorphologiescomparedtocellsontheFN9-10,
FN10, and FN9m-10 substrates. This difference was expected
since the PHSRN peptide ligand has been shown to have a lower
affinity for integrin receptors and sustain only rounded cells.
32
We observed no significant adhesion to surfaces displaying the
doublemutant protein FN9m-10m (Figure4G), whichconfirms




cell adhesion was specific for the FN protein domains. We also
performed the adhesion experiments using 3T3 cells and saw
similar results (data not shown). These results are consistent with
a previous study showing that BHK and 3T3 cells attached to
peptide surfaces presenting either PHSRN or RGD.
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To quantify the number of cells attached and spread on each
surface, BHK cells (30000 cells) were applied to monolayers for
1 h, then fixed and stained for nuclei and actin. Several images were
collectedwitha20 objective,andthenumberofcellswasaveraged
foreachsubstrateasdescribedintheExperimentalMethodssection
(Figure 5). Each of the substrates had about 20 adherent cells per
imaging frame, except the double mutant FN9m-10m, which had
less than 5 cells. The cells adherent to substrates presenting the
RGD motif had an average cell area of approximately 900 μm
2,
whereas cells on substrates having the PHSRN motif, but lacking
theRGDmotif,hadanaveragecellareaofapproximately250μm
2.
The few cells that had attached to the control surfaces devoid of
adhesive ligand also averaged 250 μm
2 in size, leading us to
designate a cell as spread if its area was above this minimum value.
For the monolayers presenting FN9 and FN9-10m, only about
20% of the cells had areas above 250 μm
2 and were designated as
spread; however, these cells maintained round morphologies due
to the decreased affinity to the substrates lacking the RGD motif.
In contrast, more than 70% of cells on monolayers presenting
FN, FN9-10, FN10, and FN9m-10 (proteins with RGD) had
cell areas above 250 μm
2, and these cells exhibited typical fibro-
blast morphologies. Also interesting, when comparing cells on
FN9-10 to those on FN10 and FN9m-10, we failed to observe
Figure 3. The expression and immobilization of the six Cut-FN
proteins was confirmed with SAMDI mass spectrometry. The
spectra show the expected products as the double- and single-
charged species. The domains constructed with mutated integrin-
bindingpeptidesequencesareindicatedingray.(A)Cut-FN9-10,
(B) Cut-FN9, (C) Cut-FN10, (D) Cut-FN9-10m, (E) Cut-
FN9m-10, and (F) Cut-FN9m-10m.
(57) Su, J.; Mrksich, M. Angew. Chem., Int. Ed. Engl. 2002, 41, 4715–4718.
(58) Yeo, W. S.; Min, D. H.; Hsieh, R. W.; Greene, G. L.; Mrksich, M. Angew.
Chem., Int. Ed. Engl. 2005, 44, 5480–5483.
(59) Patrie, S. M.; Mrksich, M. Anal. Chem. 2007, 79, 5878–5887.
(60) Marin, V. L.; Bayburt, T. H.; Sligar, S. G.; Mrksich, M. Angew. Chem., Int.
Ed. Engl. 2007, 46, 8796–8798.
(61) Mrksich, M. ACS Nano 2008, 2,7 –18.DOI: 10.1021/la901528c 13947 Langmuir 2009, 25(24), 13942–13951
Eisenberg et al. Article
a dependence of adhesion, spreading, or morphology due to the
presence of the PHSRN motif.
In a separate experiment, we allowed cells to adhere for four
hours to each of the monolayer substrates and then fixed
and immunostained the samples to compare the development of
focal adhesions (FAs) and the cytoskeleton (Figure 6). We
observed that cells spread well on the FN, FN9-10, FN10, and
FN9m-10 surfaces, and these cells also displayed abundant
vinculin-containing FA structures and organized actin cytoske-
letons spanning the entire cells. In contrast, we found almost no
localizationofvinculinand a lack oforganized actin structuresin
cellsattachedtoFN9andFN9-10m.Wefoundasimilartrendin
experiments that used 3T3 cells (data not shown).
DependenceofCellAttachmentandSpreadingonDensity
of Adhesion Ligand. Because we failed to observe a role for the
PHSRN motif in promoting attachment or spreading of cells to
monolayers presenting the RGD motif;as has been observed in
other studies that led to the proposal of the synergistic binding
model;we questioned whether the density of the RGD motif in
our substrates might be high enough to mask the role of the lower
affinity PHSRN motif. Monolayers presenting ligand at high den-
sity;relative, for example, tothe density of integrinreceptor onthe
cell surface;might mask the effect of the synergy ligand in cell
adhesion; therefore we compared cell adhesion to a series of mono-
layers where the density of ligand was decreased. Adhesion experi-
ments using substrates presenting FN9 and FN9-10m at lower
densities, however, showed a considerable reduction in the number
of attached cells (see Supporting Information Figure S1), likely due
to the lower affinity of this ligand for the integrin, as has been
previously reported.
32 We proceeded with monolayers presenting
the maleimide group at a density of 0.1% relative to total alka-
nethiolate and treated these surfaces with mixtures of the phospho-
nate reagent and 6-mercapto-1-hexanol (which serves to dilute the




4;including surfaces where all of the maleimide was conjugated
to 6-mercapto-1-hexanol and therefore unable to specifically im-
mobilize the FN proteins;in order to determine whether a synergy
effect would be observed at a lower ligand density.
Asdescribedabove,wedeterminedtheaveragenumberofcells
that attached to monolayers presenting FN9-10, FN10, and
FN9m-10foreachdensityofprotein(Figure7A).Cellsattached
Figure 4. Optical micrographs of BHK cells adherent to monolayers presenting (A) adsorbed, full length FN, (B) FN9-10, (C) FN9, (D)
FN10,(E)FN9-10m,and(F)FN9m-10,butnotto(G)FN9m-10m.Cellsalsodidnotattachtocontrolsurfacespresentingeither(H)EG3
or (I) cutinase.
Figure 5. Number of BHK cells attached and spread on protein
surfaces. The average number of attached cells per field of view
througha20 objectiveisshowninblack,andtheaveragenumber
of these cells that are spread above 250 μm
2 is indicated in white.
The data reveal a similar level of cell attachment to each of the
protein surfaces (except FN9m-10m), but few cells attached to
substrates lacking RGD were spread. The experiment was per-
formed in triplicate, and average values were determined from
images captured in five locations per chip. The asterisk indicates
that attachment to FN9m-10m was statistically significant from
attachmenttotheothersubstrateswithp<0.0005,andthepound
symbol indicates the number of spread cells on FN9, Fn9-10m,
and FN9m-10m was significantly less than the that on the other
substrates with p < 0.0005.13948 DOI: 10.1021/la901528c Langmuir 2009, 25(24), 13942–13951
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comparably to surfaces having densities of protein ranging from
0.01 to 0.1%, with approximately 20 cells attached per field of
view. For surfaces lacking the PHSRN ligand, attachment
dropped to 5-10 cells per field at densities ranging from 0.0001
to0.001%.Theselevelsofcellattachmentweresignificantlylower
than those observed to FN9-10 surfaces, where the average
numberofattachedcellsremained at13cellsand26cellsperfield
at 0.0001% and 0.001% densities, respectively. This significant
decrease in adhesion to FN10 and FN9m-10 reveals that the
presenceofPHSRNhasameasurableeffectoncellattachmentat
lower densities. Additionally, there was no cell adhesion to
substrates where the maleimide was conjugated to 6-mercapto-
1-hexanolandthenincubatedwiththeFNproteinlysates(labeled
0% relative surface density of protein), indicating these surfaces
remained inert to nonspecific protein adsorption.
We also determined the average projected areas of cells
adherent to monolayers presenting the FN9-10, FN10, and
FN9m-10 proteins at each of the densities used above
(Figure 7B). For each of the three proteins, we observed a sub-
stantial increase in average cell area as the density was increased
from 0.001 to 0.01%. For monolayers presenting the FN9-10
and FN9m-10 fragments at 0.01% density, the projected areas
averaged 1027 and 1002 μm
2, respectively, which were signifi-
cantly higher than the average area of 805 μm
2 observed with the
monolayer presenting the FN10 domain. For monolayers pre-
senting the proteins at a density of 0.05%, the average area on
FN10 increased to 910 μm
2 but was still significantly lower than
the average spread areas for cells on FN9-10 and FN9m-10. It
wasonlyatadensityof0.l%thattheprojectedareasofcellsonall
three substrates were comparable, at a value of approximately
1060μm
2.Theseresultsindicateamodestroleforthe9thdomain,
but not the PHSRN motif, in promoting cell spreading within
only a narrow range of density.
PHSRNandRGDCompetitivelyInhibitCellAttachmentto
Surfaces Presenting FN10. Given the previous experiments
where the presence of PHSRN was shown to have a modest
effect on cell attachment at low densities of protein but no effect
on cell spreading, we performed additional adhesion experiments
in the presence of soluble peptide inhibitors to determine any
Figure 6. RepresentativeBHKcellsattachedto(A)adsorbed,full
length FN, (B) FN9-10, (C) FN9, (D) FN10, (E) FN9-10m,and
(F) FN9m-10 and were fixed and stained for actin (left) and
vinculin (middle). The overlay images on the right show the
cytoskeleton in green, FAs in red, and nuclei in blue. Cells on
surfaces lacking the RGD sequence (C,E) remain poorly spread
and display less-defined cytoskeletons and FAs than those pre-
senting RGD (A,B,D,F).
Figure 7. Cell attachment and spreading were quantified for sub-
strates presenting FN9-10, FN10, and FN9m-10 at densities
ranging from 0.00001 to 0.1%. (A) Cells adhered to substrates
presenting FN9-10 at densities downto 0.0001%protein,whileno
attachment to FN10 and FN9m-10 was observed below a density
of 0.001%. The average number of cells that attached to substrates
presenting FN9-10 substrates at densities of 0.001% and 0.0001%
werestatisticallygreaterthantheaveragesforFN10andFN9m-10
at the same densities (asterisk indicates p < 0.0005). (B) Cell
spreading significantly increased for all three proteins above a
density of 0.01% protein. Cells on FN10 remained slightly less
spreadthanFN9-10andFN9m-10forsurfacespresentingprotein
at densities of 0.05% and 0.01% (asterisk indicates p < 0.0005;
poundsymbolindicatesp<0.025).Averagesweredeterminedfrom
three experiments, where seven images were captured per chip.DOI: 10.1021/la901528c 13949 Langmuir 2009, 25(24), 13942–13951
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competition between the two ligands. We have previously re-
ported that soluble PHSRN and RGD peptides competitively
inhibited cell adhesion to monolayer surfaces presenting either
peptide, although PHSRN was unable to fully prevent adhesion
to RGD substrates due to its weaker affinity for the integrin.
32
Here, we performed similar inhibition experiments to determine
whether both PHSRN and RGD peptides could block cell
adhesiontoFN10-presentingmonolayers(Figure8).Wereduced
the density of FN10 on the surface since monovalent ligands are
poor inhibitors for polyvalent cell attachment.
62 We used sub-
strate densities of 0.005% for experiments with cyclic-RGDfC,
GRGDS, as well as the scrambled GRDGS, but reduced the
density further to 0.001% with the PHSRN and HRPSN inhibi-
torsbecauseofthedecreasedligandaffinity.Also,asshowninthe
previous experiments, this range of density is where the presence
of PHSRN had a modest synergistic effect oncell attachment. As
expected, wefoundthatbothRGD peptidescompletelyinhibited
cell adhesion to FN10 with concentrations above 500 μM. We
alsofound that celladhesionwasinhibited in the presence ofPH-
SRN to 20-30% of the control at concentrations above 50 μM.
Despite the incomplete inhibition due to its weaker affinity, this
data shows that the peptide PHSRN is capable of blocking cell
adhesiontoFN10,therebycorroboratingthecompetitivebinding
mechanism for the PHSRN and RGD ligands. If PHSRN and
RGD were bound with a two-point binding mechanism, the pre-
senceofsolublePHSRNpeptidewouldnotbeabletopreventthe
integrin cell receptor from binding to the immobilized FN10 do-
main containing the RGD motif. Additionally, the lack ofinhibi-
tion shown with the scrambled GRDGS and HRPSN peptides
confirms that the interaction is specific for the peptide sequences.
Similar experiments were performed using FN9 substrates, but
the low protein density and short adhesion time prevented




substrates presenting six distinct FN fragments that include the
RGD and PHSRN motifs in active and inactive forms, we find
that both ligands can independently mediate adhesion. Cells
attach with comparable efficiency to monolayers presenting
FN9-10, FN9, FN10, FN9-10m (mutated RGD site), and
FN9m-10 (mutated PHSRN site), but fail to attach to a mono-
layer presenting the double mutant FN9m-10m. This finding
that cells are able to adhere to substrates presenting only the
PHSRN motif is consistent with recent studies,
32-34 though in
conflict with several previous reports that find that PHSRN is
unable to mediate cell adhesion itself,
21,22,24 and we address this
discrepancy below. However, we find that significant cell spread-
ing is dependent on substrates presenting an active RGD motif,




FN10 domain, which adds further support that both bind
competitively to the cell integrin receptors.
Unlike several studies that have demonstrated an apparent
synergy between the RGD and PHSRN peptide motifs,
21,22,40,42
we find that cells attach with similar efficiency to monolayers
presenting FN10 (or the analogous FN9m-10) and FN9-10.
Hence, with one exception addressed below, we find that the
presence of the PHSRN motif in the FN9 domain has little effect
onincreasingtheefficiencyofcelladhesionorspreadingwhenitis
present together with the RGD motif in the FN10 domain. We
ruleoutalackofsynergyduetoinaccessibilityoftheligand;due,
for example, to the orientationor density ofthe protein construct
on the monolayer;because monolayers presenting either
FN9m-10 or FN9-10m support cell adhesion, showing that
bothligands,whenpresentalone,interactwithintegrinreceptors.
We also note another report that suggests an additional synergis-
ticareainFN9couldberesponsibleforenhancedcellattachment
and spreading.
63 If this were the case, we would expect to see
similar levels of cell attachment and spreading for FN9-10 and
FN9m-10,butadistinctdifferenceincellareaonFN10sincethe
entire FN9 domain is lacking. We observe this to a very modest
extent, but only over a narrow range of lower densities. Taken
together, our results point toward a different modelfor adhesion,
onewherethetwo peptidesdonot bindsynergistically, but rather
have independent roles in attachment and spreading and do not
bind simultaneously to a single receptor. In an earlier report that
usedmonolayerstopresentshortpeptideligandsforstudiesofcell
adhesion, we found that both RGD and PHSRN mediated
adhesion, though the latter with substantially lower affinity.
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We also found that the addition of either peptide to the medium
could inhibit cell attachment to either peptide substrate; that is,
the two peptides bound competitively and not synergistically to
the receptor. The current findings with model substrates that
present protein domains;in place of the simplified peptide
motifs;are consistent with this earlier study.
The predominant view holds that the PHSRN peptide is a
synergy ligand and is not capable of mediating adhesion on its
own but acts to enhance cell attachment and spreading when
presented with RGD. To explain the mechanism of a synergistic
activity,ObaraandYoshizatohypothesizedthatthePHSRNand
RGD peptides bind to separate sites of a single integrin and while
the former has insufficient affinity to mediate adhesion, when
presented together with RGD, this two-point engagement dis-
plays a higher avidity for the receptor.
23 This model is consistent
Figure 8. InhibitionofBHKcellattachmentwithsolublepeptides
to surfaces presenting FN10. Suspended cells were treated with
cyclic-RGDfC, GRGDS, PHSRN, GRDGS, and HRPSN pep-
tides at concentrations ranging from 5 μM to 1 mM and then
allowed to attach to the FN10 surfaces at densities of 0.005%
(RGD)or0.001%(PHSRN).Thenumberofcellsthatattachedto
the monolayers is shown for each concentration of inhibitor
relative to the control surface that included no inhibitor. Each
datapointrepresentstheaverageofthreeindependentexperiments
with error bars omitted for clarity.
(62) Mammen, M.; Choi, S. K.; Whitesides, G. M. Angew. Chem., Int. Ed. Engl.
1998, 37, 2755–2794.
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withthecrystalstructureofthe7thto10thtypeIIIdomainsofFN
thatshows the twopeptidesresideonthe same faceofthe protein
andareseparatedbyadistancethatissuitableforinteractionwith
a single integrin.
25However, this model lacks conclusive support.
On the basis of the residual density maps from an electron
microscopy study, Arnaout suggested that FN9 is capable of
binding to the RV integrin subunit while FN10 binds to β3,
64 a
finding that is consistent with the individual crystal structures of
the integrin RVβ3
26 and FN7-10 domains.
25 Yet these EM
structures and model also propose that the integrin receptor
remains in its bent state when bound to FN7-10, a hypothesis
thathasbeencontestedandrecentlyshowntobeunlikely.
65Using
solution X-ray scattering, Mould and co-workers report struc-
turaldataforR5β1boundtoFN6-10ataresolutionof10A ˚ and
alsoclaimthatthePHSRNandRGDsiteshavedirectinteraction
with the R and β subunits of the integrin, respectively.
66
However, Takagi and co-workers reported EM structures of
R5β1andFN7-10withbothnativeandmutatedsynergyregions
and failed to find evidence for a direct contact between the
integrin and synergy site.
67 In addition, kinetic data for the
interaction of these two proteins shows that a single mutation
ofthe arginine residue (toalanine) inthe synergy region results in
a 5-fold reduction on the association rate of the complex. Further
mutations decrease the association rate another 20-fold, but the
effect on the dissociation rate is only affected 2-fold. This strong
influence over the association rate indicates that the synergy
region may enhance the probability that the proteins form a
complex following the initial integrin-FN encounter, and the
lack of an effect on the dissociation rate signifies no major role in
the stability of the protein-protein interaction. Takagi further
explains these results and questions the relevancy of the two-site
docking model in a later report.
45 Overall, these findings are
consistent with our results that the PHSRN sequence does not
assistRGD incellspreading but that itcan increasethe efficiency
of cell attachment when the ligands are present at certain
densities. Along with our inhibition studies which confirm the
two peptide ligands are competing for the same receptor binding
site, we suggest that the presence of the PHSRN site increases the
probability of initial adhesion by acting as an additional, weaker
ligandtoengagethecellintegrins,butiseventuallyreplacedbythe
stronger RGD ligand since it binds integrins with higher affinity.
A high-resolution structure of the R5β1 integrin in complex
with FNhas not yet beenreported, but wouldserve an important
role in distinguishing between the current models for the interac-
tion of PHSRN and the receptor. In an analogous system,
structures were recently reported at 2.4-2.8 A ˚ resolution for
theRIIbβ3integrinboundtotheγCandtheRGDpeptideligands
from fibrinogen.
68 These structures effectively resolved the con-
troversyoverwhetherγCandRGDcompeteforthesameRIIbβ3
integrinadhesionsiteorbindtodistinctsites.Thestructuresshow
thelysineoftheγC sequencebound inthe same integrinpocketas
the arginine residue of the RGD sequence, as well as the
penultimate aspartic acid residue of the γC sequence bound to
the metal ion-dependent adhesion site (MIDAS) as with the
aspartic acid residue of RGD peptide. For the present question
of the binding ofR5β1withPHSRNandRGD,inhibitionstudies
here and in a previous report have shown that both PHSRN and
RGD are capable of competitively binding to this integrin to
block cell adhesion to substrates presenting either peptide.
32
Another study similarly showed that both RGD and a
PHSRN-containingpeptidecould inhibittheinteraction between
the RIIbβ3 integrin and FN.
20 These reports, taken together with
theadhesiondatapresentedinthiscurrentstudy,supportamodel
where PHSRN and RGD competitively bind to the same site in
the integrin receptor to mediate cell adhesion.
The Role of Density in the Activity of PHSRN. While our
initial experiments revealed no dependence on the PHSRN motif
in the adhesion of cells to the RGD motif, and therefore were
inconsistent with several earlier studies showing a synergistic
effect, we questioned whether the density of the immobilized
protein in our study was sufficiently high that the RGD ligand
waspresentinanamountthatfarexceededthenumberofintegrin
receptors presented on the cell surface. In this limit, the addition
of an equal number of low affinity PHSRN ligands might be
expectedtohavelittleeffectonadhesion.Studieshaveshownthat




observed in this study, corresponds to about 500 integrins/μm
2.
This implies that a substrate having immobilized ligand at the
same density (500 ligands/μm
2) would potentially be sufficient to
engage each integrin on the cell surface. Previous SAM radiola-
beling experiments established that monolayers with 1% density
of ligand corresponded to nearly 40000 ligands/μm
2,
43 which is
more than enough ligand to engage each of the integrin receptors
with the higher affinity RGD peptide.
Typical substrates for adhesion studies are formed by protein
adsorption, and the ligand densities on these surfaces are known
to vary widely. Previous studies reporting a synergy effect used
substrates that were prepared by adsorbing proteins from solu-
tionsatconcentrationsrangingfrom5to200μg/mL.
21,22,71Itcan
be difficult to estimate the resulting density of active protein, but
several studies have used radiolabeled matrix proteins at these
concentrationsanddeterminedthatthetotaldensitiesofadsorbed




39,72-74 However, this method does not
identifywhatfractionofproteinwaspresentinanorientationand
conformation that allows for interaction with an integrin recep-
tor. Even ELISA cannot accurately predict the activity of an
adsorbed ligand since the antibodies typically do not bind the
same as the cell receptor. Additionally, because these substrates
arenotresistanttofurtherproteinadsorption, thesurfacedensity
of ligand can change throughout an experiment.
Massia and Hubbell performed experiments with protein-
resistant glass surfaces presenting radiolabeled RGD peptides
and were able to prepare substrates with densities ranging from
0.001 to 12000 fmol/cm
2.
39,75 They found that human foreskin
fibroblast (HFF) cells could adhere and modestly spread on
substrates having RGD present at densities as low as 1 fmol/
cm
2, although organized FA and cytoskeletal structure required
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densities of at least 10 fmol/cm
2.
39 Together with the rationale
presented above, this result implies the engagement of approxi-
mately 5-10% of the integrin receptors is sufficient to mediate
cell adhesion and spreading.
In the work reported here, we used SAM substrates to present
adhesive ligands at densities ranging from 0.00001 to 1%.
Although the ratio of alkanethiols in solution does not strictly
match the ratio of the alkanethiolates in the monolayer, our
experience and other reports
76-78 suggest that the two ratios are
similar in those cases where one oligo(ethylene glycol)-terminated
alkanethiolate is present at low density relative to a second oligo-
(ethylene glycol)-terminated alkanethiolate. We note, however,
that we have not independently verified the densities of the
peptides in the monolayer substrates. Additionally, a previous





We found that cell adhesion on FN9-10 surfaces required a
minimum density of 0.0001% (about 0.7 fmol/cm
2), a value that
generally agrees with the 1 fmol/cm
2 density that Hubbell and
Massia determined was required for minimum adhesion. How-
ever, adhesion to FN10 and FN9m-10 required a minimum
density of 0.001% or about 7 fmol/cm
2. In addition, for substrates
with protein densities of 0.0001% and 0.001%, there was a
significantly higher level of cell attachment to FN9-10 as com-
p a r e dt oF N 1 0o rF N 9 m -10. Hence, at limiting densities of
peptide, we find that the presence of the PHSRN motif with the
RGD motif increases the probability that cells will attach to the
substrates compared to those that otherwise present only RGD.
We do not believe that both the PHSRN and RGD motifs in the
same protein constructcan simultaneouslyengagedistinctintegrin
receptors, but rather that the increased density of adhesive ligands
increases the probability that a critical number of integrin recep-
tors bind to immobilized ligands during the time a suspended cell
encounters the substrate. Supporting this explanation, Springer
has presented kinetic data for the R5β1i n t e g r i nw i t haF N 7 -10
protein with several synergy mutations that shows a 5- or 26-fold
reductionoftheassociationrateofthecomplexwhencomparedto
a FN protein containing the native synergy sequence.
67 We
speculate that this effect is directly linked to the density of
immobilized ligand and that the presence of a sufficient density
of RGD renders any PHSRN ligand unnecessary.
Additionally, we did not observe a similar synergistic effect on
cell spreading. Instead, we found that the projected areas of
adherent cells significantly increased for all protein substrates
between densities of 7-70 fmol/cm
2. This threshold density of
ligand is similar to the densities reported by Massia and Hubbell,
where cell spreading was observed above a density of 1 fmol/
cm
2.
39 We do, however, find a slightly sensitive dependence of
spreadingondensityforsurfacesthatpresentFN10,ascompared
to surfaces that present both the 9th and 10th domains (FN9-10
and FN9m-10). This result, which does not depend on the
activityofthePHSRNmotif,suggeststhepotentialforadditional
sites or weak interactions other than with PHSRN to synergisti-
cally increase cell spreading, as has been suggested in another
report.
63 Overall, our studies show that PHSRN is capable of
mediating cell attachment without the presence of RGD and can
also increase cell attachment synergistically with RGD when
ligand density is low, but PHSRN has insufficient affinity to
support cell spreading and cytoskeletal organization on its own.
SAMs are Effective Model Substrates for Cell Adhesion.
The role of PHSRN in cell adhesion was first recognized some
15 years ago and was followed by the proposal of a synergy
binding model;that is, a model wherein the RGD and PHSRN
ligands interact cooperatively with independent sites on an
integrin receptor;although other data has accumulated that it
is consistent with a model wherein the two peptides are mutually
exclusive ligands for the receptor. Despite substantial work over
the past decade, the question remains open. We suggest that this
ambiguity stems from the limitations that are inherent to the
experimental tools used in studies of cell adhesion. For experi-
ments that compare cell adhesion and spreading to substrates
prepared by adsorbing protein to a material, it is impractical to
rule out effects due to changes in the conformations or orienta-
tions of the adsorbed protein. Recent work by Mardon and co-
workers maintains that the synergistic activity of the 9th domain
is dependent on its structural stability, which is presumably
related to the tendency of proteins to denature upon adsorp-
tion.
30,79 We also note an early study in this field that failed to
observe cell adhesion to a surface coated with a protein FN
fragmenthavingboththe PHSRN and RGDmotifs,aresultthat
can clearly be attributed to the ambiguities inherent to protein
adsorption.
16 Other studies have used electron microscopy to
visualize integrin-FN complexes, but these approaches have
resulted in compelling reports both in support of and against
the synergy model.
26,67 Here again, it is difficult to rule out
artifacts that stem from the interaction of the protein complex
with the electron microscopy grid and that can perturb the
equilibrium structure of the complex.
We believe that the model substrates used in this work avoid
many of these limitations and provide a functional context to
compare cell adhesion to substrates presenting fragments of the
FN protein. By allowing control over the density and orientation
of protein and by reducing artifacts associated with nonspecific
interaction of proteins with materials, the monolayers are an
effective model for identifying structure-function relationships






the lower affinity PHRSN motif has an effect in promoting
attachment. This approach using monolayers as models of the
ECM should be important for addressing a broader range of
questions in the biology of cell adhesion to the ECM.
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